The Finnish trial of prostate cancer screening: Where are we now?

Autor:	Teuvo L.J. Tammela, Pekka J. Karhunen, M. Hakama, Patrik Finne, Harri Juusela, Paula M. Martikainen, Liisa Määttänen, Jorma Lahtela, U.H. Stenman, Tuukka Mäkinen, Mirja Ruutu, Martti Ala-Opas, Jussi Aro, Anssi Auvinen, Pekka Rissanen
Předmět:	Male Oncology Pathology medicine.medical_specialty Randomization Biopsy Cost-Benefit Analysis Urology 030232 urology & nephrology 03 medical and health sciences 0302 clinical medicine Prostate Internal medicine medicine Humans Mass Screening Finland Aged medicine.diagnostic_test business.industry Medical screening Prostatic Neoplasms Anatomical pathology Middle Aged Prostate-Specific Antigen Prognosis Pedigree Prostate-specific antigen medicine.anatomical_structure Prostate cancer screening 030220 oncology & carcinogenesis Quality of Life Cost analysis business
Zdroj:	Scopus-Elsevier
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::517400987d72b64eee514d062bc343b9 http://www.scopus.com/inward/record.url?eid=2-s2.0-9144256003&partnerID=MN8TOARS Zobrazit plný text záznamu